Results from an early safety study of Moderna Inc.’s coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing antibodies at levels similar to those seen in younger adults, with side effects roughly on par with high-dose flu shots, researchers said.
Antibody levels against the novel coronavirus rose and then held steady for up to four months in more than 90% of recovered Covid-19 patients in Iceland, according to a published study.
Study Highlights Continued Concern Over Lack of Racial Diversity in Covid-19 Trials
African-Americans, Blockbusters, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, Hospitalized COVID-19 Patients, National Institute of Allergy and Infectious Diseases (NIAID), New England Journal of Medicine, R&D, Racial diversity, Rheumatoid ArthritisA recent report in the New England Journal of Medicine reveals that the racial and ethnic minority groups most negatively impacted by Covid-19 are also the least represented in these clinical studies to develop vaccines and therapeutics aimed at the disease.
The U.S. Food and Drug Administration gave the green light to AstraZeneca for a new chronic obstructive pulmonary disease (COPD) treatment, Breztri Aerosphere.
Early data released from trials of three potential coronavirus vaccines, including a closely watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight Covid-19 without serious side effects.
Moderna’s Covid-19 Vaccine Shows Early Promise
Antibodies, Clinical Trials, Coronavirus Disease 2019 (COVID-19), COVID-19 Vaccines, Data, Immune Response, Kaiser Permanente, Messenger RNA (mRNA) Vaccines, National Institutes of Health, New England Journal of Medicine, Patient safety, R&D, Researchers, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)According to data published in The New England Journal of Medicine, a Phase I trial of Moderna’s mRNA vaccine against SARS-CoV-2 demonstrated promising safety and immune response in all patients involved in the study.
Salt Water Vs. COVID-19
Coronavirus Disease 2019 (COVID-19), Gargling, Journal of Global Health, New England Journal of Medicine, Nose, Researchers, Salt Water, Scientists, Scotland, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Symptoms: Coronavirus Disease 2019 (COVID-19), University of EdinburghGargling salt water is a time-tested way to alleviate sore-throat pain. As a nasal lavage, it can help clear stuffy sinuses associated with colds and allergies. But, is gargling salt water effective against the symptoms of COVID-19?
An article raising concern about the safety of using hydroxychloroquine as a treatment of COVID-19 that forced the World Health Organization to temporarily suspend a clinical study involving the drug was retracted.
Myovant announced additional data from the company’s Phase III HERO trial of once-daily, oral relugolix in advanced prostate cancer.
A protein called ACE2 is intimately involved in how SARS-CoV-2, the virus that causes COVID-19, infects the body.